YAOPHARMA CO LTD FDA Approval ANDA 070183

ANDA 070183

YAOPHARMA CO LTD

FDA Drug Application

Application #070183

Application Sponsors

ANDA 070183YAOPHARMA CO LTD

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL25MG;250MG0METHYLDOPA AND HYDROCHLOROTHIAZIDEHYDROCHLOROTHIAZIDE; METHYLDOPA

FDA Submissions

ORIG1AP1986-01-15
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1986-12-11
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1986-12-04
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1986-12-04
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1986-12-04
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1986-12-04
MANUF (CMC); Manufacturing (CMC)SUPPL9AP1988-01-29
MANUF (CMC); Manufacturing (CMC)SUPPL11AP1988-02-17
MANUF (CMC); Manufacturing (CMC)SUPPL12AP1988-02-17
LABELING; LabelingSUPPL14AP1989-09-15
LABELING; LabelingSUPPL15AP1992-01-31
LABELING; LabelingSUPPL16AP1993-04-30
LABELING; LabelingSUPPL17AP1993-08-02
MANUF (CMC); Manufacturing (CMC)SUPPL18AP1994-01-24
MANUF (CMC); Manufacturing (CMC)SUPPL19AP1996-08-19
LABELING; LabelingSUPPL20AP1996-04-02
MANUF (CMC); Manufacturing (CMC)SUPPL22AP1998-11-25
MANUF (CMC); Manufacturing (CMC)SUPPL23AP1998-11-25
LABELING; LabelingSUPPL28AP2020-08-06STANDARD
LABELING; LabelingSUPPL29AP2020-08-20STANDARD

Submissions Property Types

SUPPL2Null0
SUPPL3Null0
SUPPL4Null0
SUPPL5Null0
SUPPL6Null0
SUPPL9Null0
SUPPL11Null0
SUPPL12Null0
SUPPL18Null0
SUPPL19Null0
SUPPL22Null0
SUPPL23Null0
SUPPL28Null15
SUPPL29Null15

CDER Filings

YAOPHARMA CO LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 70183
            [companyName] => YAOPHARMA CO LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"METHYLDOPA AND HYDROCHLOROTHIAZIDE","activeIngredients":"HYDROCHLOROTHIAZIDE; METHYLDOPA","strength":"25MG;250MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"METHYLDOPA AND HYDROCHLOROTHIAZIDE","submission":"HYDROCHLOROTHIAZIDE; METHYLDOPA","actionType":"25MG;250MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.